Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Deficit

v3.20.1
Condensed Statements of Stockholders' Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Mar. 31, 2018 $ 928 $ 2,046,056 $ (2,548,735) $ (501,751)
Balance, shares at Mar. 31, 2018 9,275,000      
Stock-based compensation expense 437,886 437,886
Stock-based compensation expense, shares      
Issuance of common stock in connection with notes payable $ 60 239,940 240,000
Issuance of common stock in connection with notes payable, shares 600,000      
Beneficial conversion feature in connection with notes payable 138,708 138,708
Net loss (1,546,935) (1,546,935)
Balance at Sep. 30, 2018 $ 988 2,862,590 (4,095,670) (1,232,092)
Balance, shares at Sep. 30, 2018 9,875,000      
Balance at Jun. 30, 2018 $ 928 2,291,086 (3,107,568) (815,554)
Balance, shares at Jun. 30, 2018 9,275,000      
Stock-based compensation expense 231,029 231,029
Stock-based compensation expense, shares      
Issuance of common stock in connection with notes payable $ 60 239,940 240,000
Issuance of common stock in connection with notes payable, shares 600,000      
Beneficial conversion feature in connection with notes payable 100,535 100,535
Net loss (988,102) (988,102)
Balance at Sep. 30, 2018 $ 988 2,862,590 (4,095,670) (1,232,092)
Balance, shares at Sep. 30, 2018 9,875,000      
Balance at Mar. 31, 2019 $ 988 3,448,857 (6,844,488) (3,394,643)
Balance, shares at Mar. 31, 2019 9,875,000      
Stock-based compensation expense $ 600 2,601,245 2,601,845
Stock-based compensation expense, shares 6,000,000      
Issuance of common stock and warrants in connection with cancellation of consulting agreement $ 10 264,510 264,520
Issuance of common stock and warrants in connection with cancellation of consulting agreement, shares 100,000      
Issuance of common stock in connection with notes payable $ 42 320,958 321,000
Issuance of common stock in connection with notes payable, shares 421,000      
Beneficial conversion feature in connection with notes payable 27,918 27,918
Net loss (5,026,430) (5,026,430)
Balance at Sep. 30, 2019 $ 1,640 6,663,488 (11,870,918) (5,205,790)
Balance, shares at Sep. 30, 2019 16,396,000      
Balance at Jun. 30, 2019 $ 1,605 4,634,601 (9,069,738) (4,433,532)
Balance, shares at Jun. 30, 2019 16,050,000      
Stock-based compensation expense 1,769,422 1,769,422
Stock-based compensation expense, shares      
Issuance of common stock in connection with notes payable $ 35 259,465 259,500
Issuance of common stock in connection with notes payable, shares 346,000      
Net loss (2,801,180) (2,801,180)
Balance at Sep. 30, 2019 $ 1,640 $ 6,663,488 $ (11,870,918) $ (5,205,790)
Balance, shares at Sep. 30, 2019 16,396,000